← Leaderboards
Debabrata Mukhopadhyay
Mayo Clinic Jacksonville
$19,437,696
Attributed
$23,156,873
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,156,873 · 10
By mechanism
R01$21,512,135 · 6
T32$973,867 · 1
R29$382,520 · 1
P50$288,351 · 1
P01$0 · 1
Top collaborators
- Mark R Spaller8 shared
- Alfredo Quinones-Hinojosa3 shared
- Dale F Mierke2 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Alfredo Quinones-Hinojosa$11,576,760
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsTumorAngiogenesisMalignant NeoplasmsMediatingPathway InteractionsTumor GrowthMolecularFutureIn VitroIn VivoExperimental DesignsGrantSignal PathwayCell LineReceptorGrowthSignal TransductionVascular PermeabilitiesNeuropilin-1BasePharmaceutical PreparationsLeadDesign
Grant awards (66)
Distinct Pathways of VPF/VEGF Receptors$653,379
R01 · FY2025 · HL · contact PI
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$556,541
R01 · FY2025 · NS
Distinct Pathways of VPF/VEGF Receptors$667,504
R01 · FY2024 · HL · contact PI
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$599,828
R01 · FY2024 · NS
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$618,380
R01 · FY2023 · NS
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$550,967
R01 · FY2021 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$512,279
R01 · FY2021 · HL · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$570,850
R01 · FY2020 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$512,279
R01 · FY2020 · HL · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$561,181
R01 · FY2019 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$542,279
R01 · FY2019 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$324,482
R01 · FY2019 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$586,058
R01 · FY2018 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$512,279
R01 · FY2018 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$334,519
R01 · FY2018 · CA · contact PI
Career Developmental Program$45,198
P50 · FY2018 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$598,146
R01 · FY2017 · CA · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$334,519
R01 · FY2017 · CA · contact PI
Career Developmental Program$111,943
P50 · FY2017 · CA · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$330,695
R01 · FY2016 · CA · contact PI
Career Developmental Program$42,686
P50 · FY2016 · CA · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$239,401
R01 · FY2015 · CA · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$96,638
R01 · FY2015 · CA · contact PI
Career Developmental Program$43,231
P50 · FY2015 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$525,901
R01 · FY2014 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$386,365
R01 · FY2014 · HL · contact PI
Career Developmental Program$45,293
P50 · FY2014 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$510,342
R01 · FY2013 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$375,326
R01 · FY2013 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$275,835
R01 · FY2013 · CA · contact PI
Tumor Microenvironment/Angiogenesis Training Grant$253,138
T32 · FY2013 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$572,715
R01 · FY2012 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$394,250
R01 · FY2012 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$293,441
R01 · FY2012 · CA · contact PI
Tumor Microenvironment/Angiogenesis Training Grant$268,004
T32 · FY2012 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$577,974
R01 · FY2011 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$394,250
R01 · FY2011 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$293,441
R01 · FY2011 · CA · contact PI
Tumor Microenvironment/Angiogenesis Training Grant$232,337
T32 · FY2011 · CA · contact PI
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside$609,472
R01 · FY2010 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$359,270
R01 · FY2010 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$302,516
R01 · FY2010 · CA · contact PI
Tumor Microenvironment/Angiogenesis Training Grant$220,388
T32 · FY2010 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$359,270
R01 · FY2009 · HL · contact PI
Regulatory Pathways and Role of VPF/VEGF in Renal Cancer$302,516
R01 · FY2009 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$359,270
R01 · FY2008 · HL · contact PI
Regulatory pathways and role of VPF/VEGF in renal cancer$265,923
R01 · FY2008 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$359,270
R01 · FY2007 · HL · contact PI
The Neurotransmitter dopamine and angiogenesis$276,869
R01 · FY2007 · HL · contact PI
Regulatory pathways and role of VPF/VEGF in renal cancer$266,529
R01 · FY2007 · CA · contact PI
Distinct Pathways of VPF/VEGF Receptors$370,000
R01 · FY2006 · HL · contact PI
The Neurotransmitter dopamine and angiogenesis$285,138
R01 · FY2006 · HL · contact PI
Regulatory pathways and role of VPF/VEGF in renal cancer$275,094
R01 · FY2006 · CA · contact PI
Distinct pathways of VPF/VEGF receptors$295,000
R01 · FY2005 · HL
The Neurotransmitter dopamine and angiogenesis$292,000
R01 · FY2005 · HL
Regulatory pathways and role of VPF/VEGF in renal cancer$282,316
R01 · FY2005 · CA
Distinct pathways of VPF/VEGF receptors$295,000
R01 · FY2004 · HL
Regulatory pathways and role of VPF/VEGF in renal cancer$292,638
R01 · FY2004 · CA
The Neurotransmitter dopamine and angiogenesis$292,000
R01 · FY2004 · HL
Neurotransmitter dopamine and angiogenesis$340,000
R01 · FY2003 · HL
Distinct pathways of VPF/VEGF receptors$340,000
R01 · FY2003 · HL
Distinct pathways of VPF/VEGF receptors$390,000
R01 · FY2002 · HL
REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCER$64,171
R29 · FY2002 · CA
Distinct Pathways of VPF/VEGF Receptors$0
P01 · FY2002 · CA
REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCER$144,869
R29 · FY2001 · CA
REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCER$173,480
R29 · FY2000 · CA